These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20092654)
1. Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: the impact of a local calibration. Calderón-Larrañaga A; Abrams C; Poblador-Plou B; Weiner JP; Prados-Torres A BMC Health Serv Res; 2010 Jan; 10():22. PubMed ID: 20092654 [TBL] [Abstract][Full Text] [Related]
2. The Medicaid Rx model: pharmacy-based risk adjustment for public programs. Gilmer T; Kronick R; Fishman P; Ganiats TG Med Care; 2001 Nov; 39(11):1188-202. PubMed ID: 11606873 [TBL] [Abstract][Full Text] [Related]
3. Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Zhao Y; Ash AS; Ellis RP; Ayanian JZ; Pope GC; Bowen B; Weyuker L Med Care; 2005 Jan; 43(1):34-43. PubMed ID: 15626932 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Rx-defined morbidity groups and diagnosis- based risk adjusters for predicting healthcare costs in Taiwan. Kuo RN; Lai MS BMC Health Serv Res; 2010 May; 10():126. PubMed ID: 20478026 [TBL] [Abstract][Full Text] [Related]
5. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012. Ha D; Song I; Lee EK; Shin JY BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic, pharmacy-based, and self-reported health measures in risk equalization models. Stam PJ; van Vliet RC; van de Ven WP Med Care; 2010 May; 48(5):448-57. PubMed ID: 20393368 [TBL] [Abstract][Full Text] [Related]
7. The Impact of Pharmacy-specific Predictors on the Performance of 30-Day Readmission Risk Prediction Models. Kabue S; Greene J; Kipnis P; Lawson B; Rinetti-Vargas G; Liu V; Escobar G Med Care; 2019 Apr; 57(4):295-299. PubMed ID: 30829940 [TBL] [Abstract][Full Text] [Related]
8. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population. Sales AE; Liu CF; Sloan KL; Malkin J; Fishman PA; Rosen AK; Loveland S; Paul Nichol W; Suzuki NT; Perrin E; Sharp ND; Todd-Stenberg J Med Care; 2003 Jun; 41(6):753-60. PubMed ID: 12773841 [TBL] [Abstract][Full Text] [Related]
9. A case-mix classification system for explaining healthcare costs using administrative data in Italy. Corti MC; Avossa F; Schievano E; Gallina P; Ferroni E; Alba N; Dotto M; Basso C; Netti ST; Fedeli U; Mantoan D Eur J Intern Med; 2018 Aug; 54():13-16. PubMed ID: 29514743 [TBL] [Abstract][Full Text] [Related]
10. Physician profiling using outpatient pharmacy data as a source for case mix measurement and risk adjustment. Roblin DW J Ambul Care Manage; 1998 Oct; 21(4):68-84. PubMed ID: 10387439 [TBL] [Abstract][Full Text] [Related]
11. Variability in prescription drug expenditures explained by adjusted clinical groups (ACG) case-mix: a cross-sectional study of patient electronic records in primary care. Aguado A; Guinó E; Mukherjee B; Sicras A; Serrat J; Acedo M; Ferro JJ; Moreno V BMC Health Serv Res; 2008 Mar; 8():53. PubMed ID: 18318912 [TBL] [Abstract][Full Text] [Related]
12. Assessing the Impact of Body Mass Index Information on the Performance of Risk Adjustment Models in Predicting Health Care Costs and Utilization. Kharrazi H; Chang HY; Heins SE; Weiner JP; Gudzune KA Med Care; 2018 Dec; 56(12):1042-1050. PubMed ID: 30339574 [TBL] [Abstract][Full Text] [Related]
13. Predictive modeling of total healthcare costs using pharmacy claims data: a comparison of alternative econometric cost modeling techniques. Powers CA; Meyer CM; Roebuck MC; Vaziri B Med Care; 2005 Nov; 43(11):1065-72. PubMed ID: 16224298 [TBL] [Abstract][Full Text] [Related]
14. Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994). Use of an ambulatory care pharmacy-derived database. Pogach LM; Hawley G; Weinstock R; Sawin C; Schiebe H; Cutler F; Zieve F; Bates M; Repke D Diabetes Care; 1998 Mar; 21(3):368-73. PubMed ID: 9540017 [TBL] [Abstract][Full Text] [Related]
15. Health-based risk adjustment: improving the pharmacy-based cost group model by adding diagnostic cost groups. Prinsze FJ; van Vliet RC Inquiry; 2007-2008 Winter; 44(4):469-80. PubMed ID: 18338519 [TBL] [Abstract][Full Text] [Related]
16. Pharmacy-and diagnosis-based risk adjustment for children with Medicaid. Kuhlthau K; Ferris TG; Davis RB; Perrin JM; Iezzoni LI Med Care; 2005 Nov; 43(11):1155-9. PubMed ID: 16224310 [TBL] [Abstract][Full Text] [Related]